Targeting antioxidant and antithrombotic biotherapeutics to endothelium.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Seminars in Thrombosis and Hemostasis

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0030-1253455PMID 20490983PMCID PMC3088482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A superoxide dismutase–human hemoglobin fusion protein showing enhanced antioxidative properties

  2009cited by this paper
• Anchoring fusion thrombomodulin to the endothelial lumen protects against injury-induced lung thrombosis and inflammation.

  2009cited by this paper
• Targeted Detoxification of Selected Reactive Oxygen Species in the Vascular Endothelium

  2009cited by this paper
• Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis.

  2009cited by this paper
• Therapeutic Effect of Lecithinized Superoxide Dismutase against Colitis

  2009cited by this paper
• Loading PEG-Catalase into Filamentous and Spherical Polymer Nanocarriers

  2008cited by this paper
• Delivery of Acid Sphingomyelinase in Normal and Niemann-Pick Disease Mice Using Intercellular Adhesion Molecule-1-Targeted Polymer Nanocarriers

  2008cited by this paper
• The inflammation–coagulation axis as an important intermediate pathway in acute lung injury

  2008cited by this paper
• Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies.

  2008cited by this paper
• Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculature.

  2008cited by this paper
• Immunotargeting of catalase to lung endothelium via anti-angiotensin-converting enzyme antibodies attenuates ischemia-reperfusion injury of the lung in vivo.

  2007cited by this paper
• Targeted delivery of catalase and superoxide dismutase to macrophages using folate.

  2007cited by this paper
• Structural Requirements for Optimized Delivery, Inhibition of Oxidative Stress, and Antiapoptotic Activity of Targeted Nitroxides

  2007cited by this paper
• Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung

  2007cited by this paper
• Delivery of Anti-Platelet-Endothelial Cell Adhesion Molecule Single-Chain Variable Fragment-Urokinase Fusion Protein to the Cerebral Vasculature Lyses Arterial Clots and Attenuates Postischemic Brain Edema

  2007cited by this paper
• Platelet-Endothelial Cell Adhesion Molecule-1-Directed Endothelial Targeting of Superoxide Dismutase Alleviates Oxidative Stress Caused by Either Extracellular or Intracellular Superoxide

  2007cited by this paper
• Amplified anticoagulant activity of tissue factor-targeted thrombomodulin

  2006cited by this paper
• Control of intracellular trafficking of ICAM-1-targeted nanocarriers by endothelial Na+/H+ exchanger proteins.

  2006cited by this paper
• Antioxidant Strategies in Respiratory Medicine

  2006cited by this paper
• Monoclonal antibodies to native mouse angiotensin-converting enzyme (CD143): ACE expression quantification, lung endothelial cell targeting and gene delivery.

  2006cited by this paper
• Superoxide Dismutase Mimetic Preserves the Glomerular Capillary Permeability Barrier to Protein

  2006cited by this paper
• Molecular Cloning and Functional Characterization of a Cell-permeable Superoxide Dismutase Targeted to Lung Adenocarcinoma Cells

  2006cited by this paper
• Endothelial Targeting of High-Affinity Multivalent Polymer Nanocarriers Directed to Intercellular Adhesion Molecule 1

  2006cited by this paper
• A hybrid vector for ligand-directed tumor targeting and molecular imaging.

  2006cited by this paper
• Endothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature.

  2005cited by this paper
• Polymer nanocarriers protecting active enzyme cargo against proteolysis.

  2005cited by this paper
• Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle

  2005cited by this paper
• Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules.

  2005cited by this paper
• ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs.

  2005cited by this paper
• Biomedical aspects of targeted delivery of drugs to pulmonary endothelium

  2005cited by this paper
• Selective rat lung endothelial targeting with a new set of monoclonal antibodies to angiotensin I-converting enzyme.

  2005cited by this paper
• Thrombin, TNF-alpha, and LPS exert overlapping but nonidentical effects on gene expression in endothelial cells and vascular smooth muscle cells.

  2005cited by this paper
• Thrombin, TNF-α, and LPS exert overlapping but nonidentical effects on gene expression in endothelial cells and vascular smooth muscle cells

  2005cited by this paper
• Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy

  2004cited by this paper
• Streptavidin-biotin crosslinking of therapeutic enzymes with carrier antibodies: nanoconjugates for protection against endothelial oxidative stress.

  2004cited by this paper
• NO and superoxide: opposite ends of the seesaw in cardiac contractility.

  2004cited by this paper
• Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture

  2004cited by this paper
• Systemic administration of platelet-activating factor in rat reduces specific pulmonary uptake of circulating monoclonal antibody to angiotensin-converting enzyme

  2004cited by this paper
• Chimeric SOD2/3 inhibits at the endothelial-neutrophil interface to limit vascular dysfunction in ischemia-reperfusion.

  2004cited by this paper
• Inflammation and thrombosis

  2003cited by this paper
• Coagulation, fibrinolysis, and fibrin deposition in acute lung injury

  2003cited by this paper
• Superoxide dismutases in the lung and human lung diseases.

  2003cited by this paper
• Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury

  2003cited by this paper
• PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress.

  2003cited by this paper
• The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases.

  2003cited by this paper
• Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress.

  2003cited by this paper
• ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface.

  2003cited by this paper
• Super-SOD: superoxide dismutase chimera fights off inflammation.

  2003cited by this paper
• Lung Endothelium Targeting for Pulmonary Embolism Thrombolysis

  2003cited by this paper
• Synthesis and anti-inflammatory activity of a chimeric recombinant superoxide dismutase: SOD2/3.

  2003cited by this paper
• A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1

  2003cited by this paper
• Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells.

  2002cited by this paper
• Cellular Handling of a Dexamethasone-Anti-E-Selectin Immunoconjugate by Activated Endothelial Cells: Comparison with Free Dexamethasone

  2002cited by this paper
• uPAR: a versatile signalling orchestrator

  2002cited by this paper
• Superoxide dismutase in aging and disease: an overview.

  2002cited by this paper
• Platelet-endothelial cell adhesion molecule-1-directed immunotargeting to cardiopulmonary vasculature.

  2002cited by this paper
• Angiotensin-(1-7)–Stimulated Nitric Oxide and Superoxide Release From Endothelial Cells

  2001cited by this paper
• Cell‐selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting

  2001cited by this paper
• Investigation of the cellular uptake of E-Selectin-targeted immunoliposomes by activated human endothelial cells.

  2001cited by this paper
• Endothelial cell protection against ischemia/reperfusion injury by lecithinized superoxide dismutase.

  2001cited by this paper
• Ultrasound Assessment of Inflammation and Renal Tissue Injury With Microbubbles Targeted to P-Selectin

  2001cited by this paper
• Vascular immunotargeting to endothelial surface in a specific macrodomain in alveolar capillaries.

  2001cited by this paper
• Inflammation and thrombosis: the clot thickens.

  2001cited by this paper
• Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting.

  2001cited by this paper
• Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody.

  2000cited by this paper
• Rapid Transport of Internalized P-Selectin to Late Endosomes and the Tgn

  2000cited by this paper
• Antibodies Against the First Ig-Like Domain of Human Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) That Inhibit PECAM-1-Dependent Homophilic Adhesion Block In Vivo Neutrophil Recruitment1

  2000cited by this paper
• Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs.

  2000cited by this paper
• Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs.

  1999cited by this paper
• A novel, 85 kDa endothelial antigen differentiates plasma membrane macrodomains in lung alveolar capillaries.

  1999cited by this paper
• Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin

  1999cited by this paper
• Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis.

  1999cited by this paper
• Platelet GPIIb-IIIa blockers.

  1999cited by this paper
• Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.

  1998cited by this paper
• Gene therapy to promote thromboresistance: local overexpression of tissue plasminogen activator to prevent arterial thrombosis in an in vivo rabbit model.

  1998cited by this paper
• Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress.

  1998cited by this paper
• Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells.

  1998cited by this paper
• Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharide.

  1997cited by this paper
• Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system.

  1997cited by this paper
• Endothelial cells internalize monoclonal antibody to angiotensin-converting enzyme.

  1996cited by this paper
• Immunotargeting of antioxidant enzyme to the pulmonary endothelium.

  1996cited by this paper
• Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats.

  1996cited by this paper
• Role of the intercellular adhesion molecule-1(ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice.

  1996cited by this paper
• Targeting of antibody-conjugated plasminogen activators to the pulmonary vasculature.

  1996cited by this paper
• Biodistribution of indium-111-labeled antibody directed against intercellular adhesion molecule-1.

  1996cited by this paper
• Immunoselective targeting of an anti-thrombin agent to the surface of cytokine-activated vascular endothelial cells.

  1995cited by this paper
• Apical topography and modulation of ICAM-1 expression on activated endothelium.

  1995cited by this paper
• Up-regulation of lung vascular ICAM-1 in rats is complement dependent.

  1995cited by this paper
• Regional differences in constitutive and induced ICAM-1 expression in vivo.

  1995cited by this paper
• A metalloporphyrin superoxide dismutase mimetic protects against paraquat-induced endothelial cell injury, in vitro.

  1995cited by this paper
• Adhesion molecules: a new target for immunoliposome‐mediated drug delivery

  1995cited by this paper
• Design and evaluation of a thrombin-activable plasminogen activator.

  1994cited by this paper
• Integrins, ICAMs, and selectins: role and regulation of adhesion molecules in neutrophil recruitment to inflammatory sites.

  1994cited by this paper
• Imaging vascular endothelial activation: an approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectin.

  1994cited by this paper
• Cytokine-activated endothelial cells internalize E-selectin into a lysosomal compartment of vesiculotubular shape. A tubulin-driven process.

  1994cited by this paper
• Lecithinized superoxide dismutase enhances its pharmacologic potency by increasing its cell membrane affinity.

  1994cited by this paper
• Interaction of mAb to angiotensin-converting enzyme (ACE) with antigen in vitro and in vivo: antibody targeting to the lung induces ACE antigenic modulation.

  1994cited by this paper
• Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.

  1992cited by this paper
• Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives.

  1992cited by this paper
• Lipopolysaccharides decrease angiotensin converting enzyme activity expressed by cultured human endothelial cells

  1992cited by this paper

• Nanomedicine for thrombotic disorders: advancing toward safer and more effective theranostics

  2025cites this paper
• Application of nanotechnology in thrombus therapy.

  2023cites this paper
• Expanding the arsenal against pulmonary diseases using surface-functionalized polymeric micelles: breakthroughs and bottlenecks.

  2022cites this paper
• Reactive Oxygen Species Scavenging Nanomedicine for the Treatment of Ischemic Heart Disease

  2022cites this paper
• Mechanisms of thrombosis and research progress on targeted antithrombotic drugs.

  2021cites this paper
• Sustained Inhibition of NF-κB Activity Mitigates Retinal Vasculopathy in Diabetes.

  2021cites this paper
• Report on biopharmaceutical profile of recent biotherapeutics and insilco docking studies on target bindings of known aptamer biotherapeutics

  2020cites this paper
• Nanodevices for the prevention and treatment of cardiovascular diseases

  2019cites this paper
• Nanodispositivos para la prevención y tratamiento de enfermedades cardiovasculares.

  2018cites this paper
• Targeting therapeutics to endothelium: are we there yet?

  2017cites this paper
• Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect

  2015cites this paper
• Endothelial targeting of nanocarriers loaded with antioxidant enzymes for protection against vascular oxidative stress and inflammation.

  2014cites this paper
• ICAM-1 Targeted Nanogels Loaded with Dexamethasone Alleviate Pulmonary Inflammation

  2014cites this paper
• Safety and pharmacokinetic studies of liposomal antioxidant formulations containing N-acetylcysteine, α-tocopherol or γ-tocopherol in beagle dogs

  2013cites this paper
• Inflammation and atherosclerosis: new biomarkers and outlooks for treatment

  2013cites this paper
• Functionalized carriers for the improved delivery of plasminogen activators.

  2012cites this paper
• Modulation of the Wound Healing Response Through Oxidation Active Materials

  2012cites this paper
• Acute toxicity study of liposomal antioxidant formulations containing N-acetylcysteine, α-tocopherol, and γ-tocopherol in rats

  2012cites this paper
• Endothelial targeting of antibody-decorated polymeric filomicelles.

  2011cites this paper
• Vascular targeting of antithrombotic agents

  2011cites this paper
• Targeted modulation of reactive oxygen species in the vascular endothelium.

  2011cites this paper
• Liposomal Antioxidants for Protection against Oxidant-Induced Damage

  2011cites this paper
• Targeted Nanocarriers for Imaging and Therapy of Vascular Inflammation.

  2011cites this paper
• Nanocarriers for vascular delivery of antioxidants.

  2011cites this paper
• SYNTHESIS AND CHARACTERIZATION OF POLYMERIC ANTIOXIDANT DELIVERY SYSTEMS

  2011cites this paper
• The Significance of Endothelial Heterogeneity in Thrombosis and Hemostasis

  2010cites this paper
• The significance of endothelial heterogeneity in thrombosis and hemostasis.

  2010cites this paper